You've watched validation projects balloon from 8 weeks to 8 months because the vendor's pack was generic and the GxP requirements weren't traced. V5 ships a CSA-aligned validation pack focused on the controls that actually matter — Part 11, Annex 11, GAMP 5 — with a published Requirements Traceability Matrix that maps every requirement to a test case and an evidence record.
Vendor validation packs are 400-page binders of irrelevant evidence — every click documented, nothing traced.
CSA-aligned pack: risk-based test scope on the Part 11 controls (audit trail, e-sig binding, access control, backup/restore). Thin, defensible, signed.
Each release breaks regression evidence — back to square one on validation.
Per-release regression evidence ships with the release, signed by V5 quality engineering. Your delta scope is the configuration only.
GAMP 5 categorisation isn't documented, so auditors push back.
V5 is documented as GAMP 5 Category 4 (configurable) with the configuration evidence per tenant. Category statement in the validation pack.
Spreadsheets and shadow IT keep slipping into the regulated scope.
Migrate regulated calculations into V5's structured fields — visible to QA, audit-trailed, signed. No more 'is this a Part 11 record?' arguments.
Validation owner can't tell what changed in a release.
Each release has a published change manifest with GxP-impact classification and the validation delta required.
Open the validation workspace. See the live RTM with green/amber/red per requirement, the test execution log, signed approvals and the open validation deviations. Click 'export inspection bundle' and hand the auditor a PDF + evidence pack.
| Metric | Before | With V5 |
|---|---|---|
| Initial validation timeline | 6–12 months | 6–10 weeks (CSA-scoped) |
| Per-release regression effort | 2–4 weeks | Configuration delta only |
| Validation pack size | 400+ page binder | Risk-based, ~80 pages, signed |
| GAMP 5 categorisation dispute | Per-audit argument | Pre-documented Cat 4 |
Validated regulated record substrate — audit trail, e-sig, change control.
IQ/OQ/PQ pack, RTM, GAMP 5 statement, periodic review SOP.
Versioned validation deliverables — VMP, URS, FS, DS, test scripts.
Validation-deviation handling and effectiveness checks.
No — it means rigour where risk is. FDA's 2022 CSA draft and ISPE GAMP 5 Second Edition both endorse focusing testing on what impacts product quality and data integrity. V5's pack does exactly that and is defensible to FDA / EMA / MHRA inspections.
Yes — V5's pack is the baseline. Most customers add a customer-specific VMP cover sheet and their own URS, then adopt V5's FS, DS and test scripts as-is.
Same validation pack, plus the additional IQ for your on-prem infrastructure (Linux host, container runtime, network segmentation). V5 ships an on-prem IQ template.
No credit card required.